Doctors Note Logo

Published on: 10/26/2026

Finasteride in Women: What It Is Used For and the Pregnancy Warning

Finasteride is sometimes prescribed off-label for women to treat female pattern hair loss, hirsutism, or hormone-related conditions like polycystic ovary syndrome, though it is not FDA-approved for these uses and results vary by dose and menopausal status. The most serious concern is pregnancy: finasteride blocks the conversion of testosterone to DHT and can cause abnormalities of the external genitalia in a male fetus, so it is contraindicated in anyone who is pregnant or may become pregnant, and even crushed or broken tablets should not be handled. Other considerations include breast tenderness, mood changes, decreased libido, menstrual irregularity, effects on PSA testing, and the need for reliable contraception, so there are several important factors to weigh before starting or continuing this medication, all explained below.

If you are noticing thinning hair, unwanted hair growth, or symptoms you suspect may be hormone related, understanding the likely cause is the first step toward the right treatment and the right safety precautions. Take a free, instant, online symptom check to get clearer insight into what may be happening and practical guidance on what to do next.

Last reviewed for medical accuracy: 10/22/2026

answer background

Concerned about your symptoms?

Explanation

What Is Finasteride?

Finasteride is a medication originally approved to treat benign prostatic hyperplasia (BPH) and male pattern hair loss. It works by blocking the enzyme 5α-reductase, which converts testosterone into dihydrotestosterone (DHT). DHT plays a key role in shrinking hair follicles and in prostate enlargement.

Though finasteride is not officially approved for women, some healthcare providers prescribe it off-label—meaning they use it in a way not specifically evaluated by the FDA—for certain female conditions rooted in high DHT levels.

Uses of Finasteride for Women

Female Pattern Hair Loss

  • Also called androgenetic alopecia, this is the most common reason finasteride is prescribed off-label in women.
  • High local DHT can miniaturize hair follicles, leading to thinning on the crown and top of the scalp.
  • Some small studies suggest daily finasteride (1–5 mg) may slow hair loss and, in some cases, promote regrowth.

Hirsutism and Polycystic Ovary Syndrome (PCOS)

  • Hirsutism (excess facial/body hair) sometimes results from elevated androgens.
  • PCOS can involve high androgen levels, irregular periods and unwanted hair growth.
  • By lowering DHT, finasteride may reduce hair growth in unwanted areas.

Other Off-Label Considerations

  • Rarely, finasteride is tried for acne linked to androgen excess.
  • Evidence is limited; topical or oral spironolactone and combined birth control pills are more commonly used.

Key Point: Always ask your healthcare provider about the strength of evidence and alternative treatments before starting finasteride.

Effectiveness

Research into finasteride’s use in women is limited. Findings generally show:

  • Modest improvement in hair counts for some women with pattern hair loss at doses of 1 mg daily.
  • Variable response—not everyone sees benefits, and it may take 3–6 months to notice changes.
  • Combination therapy with minoxidil (topical) may yield better results than finasteride alone.

In hirsutism and PCOS, studies are smaller and shorter. Some women report reduced unwanted hair growth after 6–12 months, but results can vary widely.

Side Effects and Risks

Finasteride is generally well tolerated, but side effects in women can include:

  • Hormonal changes
    • Irregular menstrual cycles
    • Breast tenderness or swelling
  • Sexual symptoms
    • Decreased libido
    • Vaginal dryness
  • Mood and cognition
    • Occasional mood swings or depression
  • Others
    • Headaches
    • Dizziness

If you experience persistent or severe side effects, stop the medication and contact your healthcare provider. Keep a symptom diary—it helps your doctor determine whether finasteride is the cause.

Pregnancy Warning

Finasteride carries a strong warning for anyone who is pregnant or may become pregnant:

  • Category X: It can cause birth defects in a male fetus, specifically affecting the development of external genitalia.
  • Handling precautions: Pregnant women should not handle crushed or broken tablets.
  • Contraception: Women of childbearing potential must use effective birth control while taking finasteride and for at least one month after stopping the drug.

If there’s any chance you could become pregnant, discuss safer alternatives with your doctor. Always read the medication guide and follow your provider’s instructions carefully.

Getting Help and Next Steps

  1. Assess your symptoms
    If you’re worried about hair loss, unwanted hair growth, or hormonal symptoms, start with a
    free, online symptom check, using the doctor approved Ubie Symptom Checker.
    It can help you organize your concerns before seeing a healthcare professional.

  2. Consult your doctor

    • Share your medical history, including any attempts at treatment so far.
    • Discuss the pros and cons of off-label finasteride versus other therapies.
    • Ask about monitoring plans (blood tests, follow-up visits).
  3. Evaluate alternatives

    • Topical minoxidil for hair loss
    • Spironolactone or combined oral contraceptives for androgen-related issues
    • Lifestyle changes (diet, stress management) that support hormonal balance
  4. Monitor and adjust

    • Track any benefits or side effects for at least 3–6 months.
    • Stay in touch with your healthcare provider to adjust dose or switch treatments if needed.

When to Seek Immediate Medical Attention

Speak to a doctor right away if you experience:

  • Signs of an allergic reaction (rash, swelling, difficulty breathing)
  • Severe mood changes or thoughts of self-harm
  • Sudden, unexplained weight gain or leg swelling
  • Any symptom that feels life threatening or out of the ordinary

Your health matters. Always rely on a qualified provider for personalized guidance.


Finasteride may offer hope for some women struggling with androgen-driven hair or skin issues, but it’s not a one-size-fits-all solution. Balancing benefits against potential risks—especially for women of childbearing age—is essential. By partnering with a knowledgeable doctor, tracking your progress, and using tools like the Ubie Symptom Checker, you can make informed decisions about whether finasteride is right for you.

(References)

  • * Reddy DS, Kim HY, Rogawski MA. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia. 2001 Mar;42(3):328-36. doi: 10.1046/j.1528-1157.2001.10100.x. PMID: 11442149.

  • * Tosti A, Piraccini BM, Sisti A, Duque-Estrada B. Hair loss in women. Minerva Ginecol. 2009 Oct;61(5):445-52. PMID: 19749676.

  • * Chiba K, Yamaguchi K, Li F, Ando M, Fujisawa M. Finasteride-associated male infertility. Fertil Steril. 2011 Apr;95(5):1786.e9-11. doi: 10.1016/j.fertnstert.2010.12.001. Epub 2010 Dec 30. PMID: 21193189.

  • * Modol L, Casas C, Navarro X, Llidó A, Vallée M, Pallarès M, Darbra S. Neonatal finasteride administration alters hippocampal α4 and δ GABAAR subunits expression and behavioural responses to progesterone in adult rats. Int J Neuropsychopharmacol. 2014 Feb;17(2):259-73. doi: 10.1017/S1461145713000989. Epub 2013 Sep 9. PMID: 24011224.

  • * Teichert M, van Puijenbroek E, Stricker BH. Contraindicated use of 5-alpha-reductase inhibitors in women. Br J Clin Pharmacol. 2017 Feb;83(2):429-431. doi: 10.1111/bcp.13118. Epub 2016 Sep 30. PMID: 27567019; PMCID: PMC5237684.

  • * Zouboulis CC, Dessinioti C, Tsatsou F, Gollnick HPM. Anti-acne drugs in phase 1 and 2 clinical trials. Expert Opin Investig Drugs. 2017 Jul;26(7):813-823. doi: 10.1080/13543784.2017.1337745. Epub 2017 Jun 19. PMID: 28627277.

  • * Kalakh S, Mouihate A. Enhanced remyelination during late pregnancy: involvement of the GABAergic system. Sci Rep. 2019 May 22;9(1):7728. doi: 10.1038/s41598-019-44050-4. Epub 2019 May 22. PMID: 31118452; PMCID: PMC6531481.

  • * Maldarine JS, Sanches BDA, Cabral ÁS, Lima MLD, Guerra LHA, Baraldi CMB, Calmon MF, Rahal P, Góes RM, Vilamaior PSL, Taboga SR. Prenatal exposure to finasteride promotes sex-specific changes in gerbil prostate development. Reprod Fertil Dev. 2019 Oct;31(11):1719-1729. doi: 10.1071/RD19106. PMID: 31248476.

  • * Salisbury BH, Leslie SW, Tadi P. 5α-Reductase Inhibitors. 2024 Jan. PMID: 32310390.

  • * Finasteride. 1994. PMID: 35951971.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.